Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for proliferation of mouse embryonic stem cells that are undergoing differentiation

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

This study found that increased expression of PFKFB3 is required for the proliferation of mouse embryonic stem cells undergoing differentiation and that PFKFB3 silencing induces differentiation markers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The preprint studied how 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoenzymes (PFKFB1–4) change during mouse embryonic stem cell (mESC) differentiation, comparing undifferentiated R1 and J1 mESCs cultured with LIF to conditions produced by LIF removal. Expression of Pfkfb3 was markedly increased after differentiation induction, and Pfkfb3 silencing increased the differentiation marker Brachyury, while Pfkfb3 upregulation was required for proliferation of early differentiated mESCs. The authors used qPCR, western blotting, siRNA knockdown, and ectopic Pfkfb3 expression, but the study notes a need for further mechanistic work to define the pathways controlling proliferation and early differentiation through Pfkfb3. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The unlimited proliferation capacity of embryonic stem cells (ESCs) coupled with their capability to differentiate into several cell types makes them an attractive candidate for studying the molecular mechanisms regulating self renewal and transition from pluripotent state. Although the roles of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase family (PFKFB1-4) in cell survival, proliferation, and differentiation in tumor cells have been studied, their role in mESCs biology is currently unkown. In the current study, Pfkfb isozyme expressions were analyzed in undifferentiated R1 and J1 mouse embryonic stem cells (mESCs) that were cultured in the presence and absence of leukemia inhibitory factor (LIF). We report that expression of the Pfkfb3 isoenzyme was markedly increased when mESCs were promoted to differentiate with LIF removal. We then demonstrated that Pfkfb3 silencing induced the differentiation marker Brachyury suggesting that Pfkfb3 may be required for the regulation of mesodermal differentiation of mESCs. Furthermore, we show that the increase in Pfkfb3 expression is required for the proliferation of early differentiated mESCs. Although these results provide important insights into the early differentiation of mESCs with regard to Pfkfb expressions, further mechanistic studies will be needed for understanding the pathways and mechanisms involved in regulation of proliferation and early differentiation of mESCs through Pfkfb3.
Full text 84,190 characters · extracted from preprint-html · click to expand
Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for proliferation of mouse embryonic stem cells that are undergoing differentiation | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for proliferation of mouse embryonic stem cells that are undergoing differentiation Saime Guzel, Yunus Gurpinar, Tugba Hazal Altunok, Abdullah Yalcin This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-2068671/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 7 You are reading this latest preprint version Abstract The unlimited proliferation capacity of embryonic stem cells (ESCs) coupled with their capability to differentiate into several cell types makes them an attractive candidate for studying the molecular mechanisms regulating self renewal and transition from pluripotent state. Although the roles of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase family (PFKFB1-4) in cell survival, proliferation, and differentiation in tumor cells have been studied, their role in mESCs biology is currently unkown. In the current study, Pfkfb isozyme expressions were analyzed in undifferentiated R1 and J1 mouse embryonic stem cells (mESCs) that were cultured in the presence and absence of leukemia inhibitory factor (LIF). We report that expression of the Pfkfb3 isoenzyme was markedly increased when mESCs were promoted to differentiate with LIF removal. We then demonstrated that Pfkfb3 silencing induced the differentiation marker Brachyury suggesting that Pfkfb3 may be required for the regulation of mesodermal differentiation of mESCs. Furthermore, we show that the increase in Pfkfb3 expression is required for the proliferation of early differentiated mESCs. Although these results provide important insights into the early differentiation of mESCs with regard to Pfkfb expressions, further mechanistic studies will be needed for understanding the pathways and mechanisms involved in regulation of proliferation and early differentiation of mESCs through Pfkfb3. Mouse embryonic stem cells 6-Phosphofructo-2-kinase/Fructose 2 6-bisphosphatase-3 Brachyury Leukemia inhibitory factor Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Introduction Pluripotent stem cells (PSCs) are characterized by their unlimited capacity for self-renewal and their potential to differentiate into all cell lineages of three primary germ layers. Different states of pluripotency exhibit slightly different features. The naive state represents the inner cell mass (ICM) of the early blastocyst while the primed state is representative of the early post-implantation epiblast cells. After implantation occurs, the epiblast cells progressively lose expression of pluripotency genes such as Oct4 and Nanog (Weinberger et al. 2016 ; Mathieu et al. 2017 ). Embryonic stem cells (ESCs) are derived from the ICM of pre-implantation blastocyst stage of embryos. Mouse ESCs (mESCs) resemble naive state whereas post-implantation epiblast stem cells (mEpiSCs) and human ESCs (hESCs) are considered a primed PSC. While leukemia inhibitory factor (LIF) is a crucial factor for robust self-renewal of mESCs, mEpiSCs can be grown in vitro without LIF in the presence of activin A and fibroblast growth factor (FGF) (Brons et al. 2007 ; Tesar et al. 2007 ). During culture, EpiSCs exhibit a high propensity for spontaneous differentiation (Kurek et al. 2015 ). The transition from the mESC to the mEpiSC state is the initial important step for ESCs to commit to differentiation. In vitro, first stages of spontaneous differentiation of mESCs can mimic this transition, but the mechanisms underlying this process are largely unknown. PSCs exhibit a lower rate of Oxidative Phosphorylation (OXPHOS) than their differentiated counterparts; however, metabolism in naive and primed pluripotency occurs differently. Glycolysis is common to all stages of pluripotency; however, the relative contributions of glycolysis versus OXPHOS can differ in different stages of pluripotency. While mEpiSCs and hESCs are almost exclusively glycolytic, mESCs use both glycolysis and OXPHOS pathways (Lee et al. 2012 ; Zhou et al. 2012 ; Si et al. 2013 ; Mu et al. 2015 ; Cha et al. 2017 ). Early embryonic development occurs in a hypoxic environment which occurs as a result of the high oxygen consumption and cellular proliferation of the rapidly growing embryo. In a hypoxic environment, the heterodimeric transcription factor hypoxia-inducible factor 1 (HIF1α), the main regulator of molecular response to hypoxia, plays a crucial role in tissue formation and stem cell homeostasis. HIF-1α upregulation stimulates the expression of glycolytic genes such as hexokinase (HK), lactate dehydrogenase (LDH), pyruvate dehydrogenase kinase (PDK1). Elucidation of the metabolic genes and pathways that are involved in pluripotency, differentiation, and proliferation of ESCs may help us better understand the molecular basis of early embryonic development as well as devise therapeutic strategies for various indications. Glycolysis is indirectly regulated by the bifunctional 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatases isoenzymes (PFKFB1-4) which determine the intracellular concentration of fructose 2,6-bisphosphate (F2,6BP)-a shunt product of glycolysis and allosteric activator of one of the rate-limiting enzymes of glycolysis, 6-phosphofructo-1-kinase (PFK-1) (Yalcin et al. 2009 ). PFKFB enzymes have been shown to be involved in cell proliferation (Yalcin et al. 2014 ), cell survival (Domenech et al. 2015 ), cell differentiation (Hamanaka et al. 2017 ), and tumor growth (Clem et al. 2008 ). A recent study (Novellasdemunt et al. 2013 ) has revealed that the mouse Pfkfb3 mRNA becomes detectable during the blastocyst stage of embryogenesis. Chesney et al. ( 2005 ) demonstrated that the genomic deletion of Pfkfb3 results in embryonic lethality. Pegoraro et al. ( 2013 ) shows that tissue-specific, dynamic and complementary expression pattern of the PFKFB genes play an important role in the developmental stage of the Xenopus laevis (African clawed frog) embryos from blastula to tadpole stages. In another recent study by the same team (Pegoraro et al. 2015 ), Pfkfb4, by acting through Akt signaling pathway, has been shown to be essential in the development of frog embryos and differentiation of progenitor cells. However, studies on potential roles of Pfkfb isoenzymes in stem cell differentiation and metabolism are scarce. In the current study, we studied the expression of Pfkfb isoenzymes in mESCs that are self-renewing (in the presence of LIF) and that are induced to spontaneously differentiate (upon LIF removal). We show, for the first time, that the differentiation of mESCs for 5 day (d) upon LIF removal resulted in an increase in Pfkfb3 expression. In addition, we demonstrate that the Pfkfb3 silencing was associated with the increased expression of the differentiation marker Brachyury. We further demonstrate that increased expression of Pfkfb3 is required for the proliferation of early differentiated mESCs in vitro. Materials And Methods Cell culture and mESC differentiation Mouse embryonic stem R1 (ATCC, SCRC1036) and J1 (ATCC, SCRC 1010) cell lines were grown in tissue culture dishes (Corning, Amsterdam, The Netherlands) coated with 0.1% gelatin (Sigma, Munchen, Germany) in a Dulbecco’s modified Eagle’s medium (DMEM) (Sigma, Munchen, Germany) supplemented with 15% ESC-qualified fetal bovine serum (Sigma, Munchen, Germ any), 0.1mM MEM non-essential amino acids (Sigma), 0.1 mM 2-mercaptoethanol (Sigma, Munchen, Germany), L glutamin (Sigma), 100 U/ml penicillin-100 ug/ml streptomisin mix and 1000 units/ml of recombinant mouse LIF. mESCs were cultured at 37°C in a humidified atmosphere with 5% CO2. Cells were passaged every 3 or 4 d using trypsin EDTA. Media were changed every 2 d. Spontaneous differentiation was induced with the removal of LIF from media. Real-time quantitative PCR (qPCR) Total RNA was isolated using a commercial kit (Thermo Fisher Sci.) and reverse-transcribed using an mRNA to cDNA synthesis kit (Thermo Fisher Sci. Cat.#4387406) according to manufacturer’s directions. mRNA expressions of Pfkfb1, Pfkfb2, Pfkfb3, Pfkfb4, Brachyury (T2), Nestin (Nes), Oct4, Sox2, Nanog, Klf4 mRNA expressions, were determined by qPCR using StepOnePlus (Thermo Fisher Sci., NY, USA) with TaqMan probes (Thermo Fischer Sci., Cat.#s: Pfkfb1, Mm01256237_m1; Pfkfb2, Mm00435575_m1; Pfkfb3, Mm00504650_m1; Pfkfb4, Mm00557176_m1; T2, Mm00436877_m1; NES, Mm00450205_m1; Oct4, Mm03053917_g1; Sox2, Mm03053810_s1; Nanog, Mm02019550_s1; Klf4, Mm00516104_m1; Gapdh, Mm99999915_g1). Gapdh was used as housekeeping gene control for normalization of cDNA. Cycle threshold (CT) values were taken from qPCR reactions and up/down regulation of genes of interest was determined by the ΔΔCT method using undifferentiated mESCs as a baseline (Livak et al. 2001 ). SDS-PAGE and Western blotting SDS-PAGE and Western blotting were performed following standard protocols. Primary antibodies specific to Pfkfb3 (Proteintech Cat.#13763-1-AP), P-Stat3 (Cell Signaling Cat.#9145), Stat3 (Cell Signaling Cat.#9139), Nanog (Cell Signaling Cat.#8822), and Gapdh (Cell Signaling Cat.#97166) proteins were used. Appropriate horseradish peroxidase-conjugated secondary antibodies (goat anti-rabbit, Cell Signaling Cat.#7074 or anti-mouse Cell Signaling Cat.#7076) were used. Signals were developed using Amersham ECL plus chemoluminescent reagent (GE Technologies). Bands on membranes were visualized with ChemiDoc MP (BioRad). siRNA and plasmid transfection Transfections of and Pfkfb3-specific (Thermo Fischer Sci. Cat.#100779) siRNA molecules into cells was performed in serum-free and antibiotic-free medium using Lipofectamine RNAiMAX (ThermoFisher Sci.) following the manufacturer’s recommendations when cells reached approximately 50% confluency at the time of transfection. As a negative control, cells were transfected with the universal siRNA molecule, which has no homology in the human genome (Thermo Fischer Sci. Cat.# 4390846). Cells were incubated in complete medium at 37°C for 48 hours before cell harvest or further experiments. The final concentrations of siRNA molecules were 10 nM. For ectopic expressions, pCMV6-A-BSD expression vector encoding Pfkfb3 cDNA (Origene Cat. #MG227622) was transfected into cells using Lipofectamine 3000 reagent (ThermoFisher Sci.) following the manufacturer’s instructions. Cells were 70–80% confluent at the time of transfection. Cell proliferation Pluripotent and differentiated (for 5 d) mESCs were lifted with trypsin post-transfections and stained with trypan blue for 1 min. The numbers of viable cells were counted under an inverted microscope (Accu-Scope, China) using hemocytometer (Neubauer improved) as per standard protocol. Fructose 2,6-bisphosphate assay Intracellular fructose 2,6-bisphosphate (F2,6BP) levels of differentiated (for 3 and 5 d) and undifferentiated mESCs were analyzed following a Kinetic spectrophotometric coupled enzyme method described by Van Schaftingen et al. ( 1982 ). The protocol briefly as follows; mESCs were centrifuged at 270×g and resuspended in 20 volumes of 0.05 N NaOH and then 1 volume of 0.1 N NaOH vortexed for 10 s, heatted at 80°C for 5 min, and cooled in an ice bath. PH of lysates adjusted to 7.2 with ice-cold 1M acetic acid in the presence of 1M Hepes. Next, samples were incubated at 25°C for 2 min in the assay mixture. The contents of the assay mixture were as follows: 50 mM Tris, 2 mM Mg ⁺2 , 1 mM Fru-6-P, 10 units/liter PPi-dependent PFK1, 0.15 mM NAD, 5 kilounit/liter triose-phosphate isomerase, 0.45 kilounit/liter aldolase, and 1.7 kilounit/liter glycerol-3-phoshate dehydrogenase (Sigma). Reaction was started adding 0.5 mM Pyrophosphate and the rate of changes in absorbance (OD 339 nm) per min was analyzed in 5 min. F2,6BP levels were calculated based on a calibration curve ranging from 0.1 to 1.0 pmol standart of Fru-2,6-BP (Sigma) and normalized to total cellular protein levels. Glucose uptake assay To determine glucose uptake by pluripotent and differentiated (for 5 d) mESCs, a commercial glucose uptake kit (BioVision, Milpitas, CA, USA) was used in accordance with the manufacturer's instructions. The principle of this assay is briefly as follows: 2-deoxyglucose (2-DG) is metabolized to 2-DG-6-phosphate (2-DG6P) which cannot be further metabolized, and thus accumulates in the cells. The accumulated 2-DG6P is directly proportional to 2-DG (or glucose) uptake by cells. 2-DG6P is oxidized to generate NADPH, which can be determined by an enzymatic recycling amplification reaction. ALP staining Alkaline phosphatase (ALP) Live Stain kit (Thermo Fischer Sci. Cat.#A14353) was used to determine ALP activity in pluripotent and differentiated mESCS. Staining was performed for 20–30 min according to manufacturer's instructions. The protocol was briefly as follows; R1 and J1 mESCs were washed twice with sterile, fresh, pre-warmed basal DMEM/F-12 media. For differentiated and undifferentiated mESCs, 1X working solution which was prepared by diluting the 500X stock solution of the LIVE AP substrate in basal DMEM/F-12 media, was found to be optimal in providing a potent signal. The ALP live stain dye was immediately applied on to the adherent mESC culture. mESCs were incubated with the substrate for 20–30 min and washed twice with the DMEM/F-12 basal media to remove excess substrate. After the final wash, fresh basal media was added and fluorescent-labeled colonies were imaged on EVOS Imaging System (ThermoFischer Sci.). The most robustly fluorescing colonies were selected for imaging within 30–40 min of staining. Statistical analysis The Statistical Package for the Social Sciences version 23.0 (SPSS, Chicago, IL, USA) was used for data analyses. Values were expressed as means ± standard deviation. Statistical analysis was performed using Student’s t-test and results were considered to be significant when p value was < 0.05. Results And Discussion LIF withdrawal induces differentiation of mESCs The LIF/STAT3 pathway has a crucial role in maintaining the self renewal and pluripotency of the mESCs (Raz et al. 1999 ; Hirai et al. 2011 ). Upon the withdrawal of LIF, mESCs rapidly exit from the pluripotent state in vitro. A recent study in mESCs has shown that LIF remowal induces transition from the naive pluripotent state to the primed-like state with expression of early differentiation markers through activation of mTOR (Cherepkova et al. 2016 ). First, we evaluated the morphological features of R1 and J1 mESCs growing in the absence or presence of LIF. The morphology of the cells that are induced to differentiate for 5 d acquired some morphological characteristics compared to undifferentiated mESCs. While undifferentiated R1 and J1 mESCs grew as compact, dome-shaped colonies, the cells appeared more scattered, less compact and more flattened upon LIF removal (Fig. 1 A). qPCR analysis demonstrated that the LIF withdrawal from media in R1 and J1 mESCs for 5 d led to decreases in expression levels of pluripotency genes, including Oct4 (R1, p˂0.05; J1, p˂0.01), Klf4 (p˂0.01), Sox2 (p˂0.01) and Nanog (p˂0.05) (Fig. 1 B). A recent study showed that the induction of early differentiation in LIF-depleted mESCs proceeds by KLF4-mediated regulation of pluripotency related pathways (Cherepkova et al. 2016 ). Western blot analysis was used to confirm the decrease in the Nanog protein in differentiated R1 mESCs (Fig. 1 D). Consistent with downregulation of pluripotency gene marker expressions, mRNA levels of brachyrury (R1, p˂0.01; J1 p˂0.05), a widely used early marker of mesodermal differentiation and Nestin (R1 and J1, p˂0.01) (Fig. 1 C), a neuroectodermal stem cell marker, were upregulated upon LIF removal. Among the intracellular signaling pathways that are regulated by LIF, Jak-Stat3 is known to be essential for the self-renewal and pluripotency of mESCs (Niwa et al. 2009 ). Upon LIF stimulation, Stat3 is phosphorylated and activated by Jaks, which subsequently stimulates the expressions of various pluripotency-associated genes (Hirai et al. 2011 ; Cherepkova et al. 2016 ). We checked the phosphorylation of the Stat3 protein in the presence or absence of LIF and found that LIF removal reduced Stat3 phosphorylation (Fig. 1 D). Alkaline phosphatase activity is another valuable marker for pluripotent mESCs. High ALP activity in pluripotent mESCs is reduced or lost upon differentiation (Piquet-Pellorce et al. 1994 ; Hong et al. 1996 ). We therefore went on to determine ALP activity in undifferentiated and differentiated mESCs. As expected, while the undifferentiated R1 and J1 mESCs displayed a robust ALP activity as asssessed by staining of the cells with a fluorescent ALP subsrate, the LIF-depleted cells displayed no activity (Fig. 1 E), suggesting that LIF removal induced the differentiation of mESCs. Early differentiation of mESCs leads to an increase in Pfkfb3 expression Although the roles of Pfkfb isoenzymes in proliferation and survival of tumor cells are well-studied (Yalcin et al. 2014 ; Peng et al. 2018 ), potential roles of Pfkfb3 isoenzymes in proliferation and differentiation of mESCs are currently unknown. We first compared the expressions of Pfkfb isoenzymes in undifferentiated and early differentiated mESCs. J1 and R1 mESCs were cultured in the presence and absence of LIF for 5 d and mRNA levels of Pfkfb genes (Pfkfb1-4) were determined using qPCR. LIF withdrawal in both cell lines resulted in an increase in the expression of Pfkfb3 (p˂0.001) and Pfkfb4 (p˂0.05) isoenzymes, while no significant differences were determined in the expressions of Pfkfb1 and Pfkfb2 isoenzymes (Fig. 2 A). Because the most significant increase was observed with Pfkfb3 expression, we focused our attention on this isoform. Increased Pfkfb3 mRNA expressions in differentiated R1 and J1 mESCs coincided with increases in Pfkfb3 protein levels as assessed by Western blot analyses (Fig. 2 B). Consistent with the increases in mRNA and protein levels of Pfkfb3 isoenzyme, the intracellular F2,6BP level was significantly elevated in early differentiated mESCs (3 d and 5 d) relative to undifferentiated mESCs (p < 0.001) (Fig. 2 C). LIF-depleted mouse ESCs have been shown to transit from the pluripotent state to the primed-like state, which exhibits a glycolytic phenotype (Zhou et al. 2012 ). Our findings show that a higher Pfkfb3 and F2,6BP levels upon LIF removal are consistent with the glycolytic phenotype reported by Zhou et al. ( 2012 ). However, we found that LIF-depleted cells exhibited a diminished glucose uptake compared with undifferentiated R1 mESCs (p˂0.05) (Fig. 2 D). Although it is difficult to reconcile these seemingly contradictory findings, as increased Pfkfb3 and F2,6BP levels are known to be associated with increased glucose uptake and glycolytic activity, we speculate that, given the dymanic feature of differentiation, the reliance of mESCs undergoig differentiation on glycolysis vs. OXPHOS may markedly be divergent in various stages of differentiation. For example, the highly glycoltic mESCs during the early stages of differentiation ( 5 d). Lending support to this hypothesis, the study by Ando et al. ( 2010 ) that was published during the preparation of our manuscript that showed a diminished glucose uptake that coincided with a decreased Pfkfb3 level on day 6 compared with day 3 postdifferentiation in early differentiated adipocytes. However, we refrain from over-speculating regarding the data, as the setup and cell types were different in these studies. Another likely scenario is that given that the activation of the IL-6/STAT3 pathway in LIF-containing media induces glycolysis as shown by Ando et al. ( 2010 ), and that removing LIF may have uncoupled glucose uptake and glycolysis from pluripotency signals such as STAT3. In this scenario, although glucose uptake was reduced with LIF removal, the induction of Pfkfb3 may be necessary to maintain the glucose uptake and glycolytic flux in early differentiation of mESCs. The observed upregulation of Pfkfb3 may reflect a compensatory feedback mechanism in LIF-depleted (day 5) mESCs and may diminish on further days of differentiation, which will require further investigations. Pfkfb3 silencing induces Brachyury expression in mESCs. The mouse Brachyury (T) is a key regulator of mesoderm formation during early embryonic development (Zhu et al. 2016 ) and essential for epithelial mesenchymal transition (EMT) which is important for embryonic development and EpiSCs differentiation (Kim et al. 2014 ; Song et al. 2016 ). Although there are studies suggesting the involvement of Pfkfb3 on differentiation of preadipocytes (Griesel et al. 2021 ) and epidermal keratinocytes (Hamanaka et al. 2017 ), the potential role of Pfkfb3 in early differentiation of mESCs is unknown. To investigate the requirement of Pfkfb3 for the early differentiation of mESCs, we analyzed gene expression levels of the differentiation markers brachyrury and nestin in control- or Pfkfb3-siRNA transfected ceIls, in the presence and absence of LIF. qPCR analyses demonstrated that the Pfkfb3 gene silencing led to an increase in the expression level of Brachyury gene in both of differentiated and undifferentiated mESC lines (p˂0.05), while there were no changes in the expressions of nestin gene (Fig. 3 : average mRNA fold changes of siNTCs or siPF3s; Brachyury : R1 cell line LIF+, siNTC = 1 ± 0.17 and siPF3 = 1.99 ± 0.35; LIF-, siNTC = 1,99 ± 0.55 and siPF3 = 2.55 ± 0.42; J1 cell line LIF+, siNTC = 1 ± 0.19 and siPF3 = 1.58 ± 0.36; LIF-, siNTC = 2,17 ± 0.19 and siPF3 = 3.05 ± 0.36; Nestin : R1 cell line LIF+, siNTC = 1 ± 0.048 and siPF3 = 0.91 ± 0.02; LIF-, siNTC = 2.52 ± 0.40 and siPF3 = 2.29 ± 0.02; J1 cell line LIF+, siNTC = 1 ± 0.03 and siPF3 = 0.98 ± 0.04; LIF-, siNTC = 5.57 ± 0.15 and siPF3 = 5.80 ± 0.18) and pluripotency gene markers, Sox2, Nanog, Oct4, Klf4 ( data not shown ). These data suggest that Pfkb3 may have a role in the regulation of barchyury-mediated mesodermal differentiation of mESCs in the early embryonic period, which is consistent with a recent study demonstrating that Pfkfb3 knockdown promoted the differentiation of epidermal keratinocytes (Hamanaka et al. 2017 ). Increase in Pfkfb3 expression is required for proliferation of early differentiated mESCs Given the known role of Pfkfb3 in cell proliferation (Yalcin et al. 2009 , 2014 ), we then evaluated cell counts in the presence and absence of LIF after Pfkfb3 siRNA transfection and overexpression. We first confirmed the effiency of Pfkfb3 mRNA targeting by the siRNA approach using qPCR (Fig. 4 A). We found that while Pfkfb3 depletion led to a decreased cell counts upon LIF withdrawal, it increased cell counts in the presence of LIF (p˂0.05) (Fig. 4 B). We then ectopically transfected R1 and J1 mESCs in the presence and absence of LIF with expression vector carrying Pfkfb3 (Pfkfb3-V) and empty plasmid for control. Ectopic transfections led to marked increases in Pfkfb3 mRNA levels (Fig. 5 A). In contrast to the Pfkfb3 silencing, ectopic Pfkfb3 expression reduced the proliferation of mEScs growing in the presence of LIF but stimulated the growth of mESCs that are induced to spontaneously differentiate with LIF removal (Fig. 5 B). Consistent with a decrease in glucose uptake upon LIF removal, cell proliferation was diminished in LIF-depleted cells. Our observation that Pfkfb3 depletion further reduces the proliferation of early differentiated mESCs suggests that mESCs that are undergoing spontaneous differentiation may rely on increased Pfkfb3 levels to maintain glycolytic phenotype that is associated with proliferation. Conclusion In summary, the present study demonstrates that LIF-depletion induces Pfkfb3 expression and that Pfkfb3 may be required for differentiation and proliferation of mESCs. Mechanistic studies will be needed to fully delineate the requirement of PFKFB isoenzymes for differentiation of stem cells into specialized cells. Better understanding of specific molecular mechanisms or pathways of stem cell differentiation may provide us with valuable tools that can be exploited in various disciplines of medicine. Abbreviations PFKFB, 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase; mESCs, mouse embryonic stem cells; LIF, leukemia inhibitory factor. Declarations Acknowledgements This work was supported by the Scientific Research Fund of Bursa Uludag University [grant number# OUAP(V)-2013/27] and Scientific and Technological Research Council of Turkey [grant number#116Z570). Funding This work was supported by the Scientific Research Fund of Bursa Uludag University [grant number# OUAP(V)-2013/27] and Scientific and Technological Research Council of Turkey [grant number#116Z570). Author Information Authors and Affiliations Department of Biochemistry, School of Veterinary Medicine, Bursa Uludag University, Bursa, Turkey Saime Guzel, Tugba H Altunok, Abdullah Yalcin Research Center for Translational Medicine, Koc University, Istanbul 34010, Turkey Yunus Gurpinar Contributions Conceptualization: SG & AY; Acquisition and Analysis: SG, THA & YG; Funding Acquisition: SG; Writing: SG; Review and Editing: AY Corresponding Author Correspondence to Abdullah Yalcin or Saime Guzel Ethics Declarations Conflict of interest The authors declare that they have no conflicts of interests. Ethics Approval Not applicable Consent to participate Not applicable Data Availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. References Ando M et al (2010) Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. J Nippon Med Sch 77: 97-105. Brons I et al (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195. Cha Y et al (2017) Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis. Nat Cell Biol 19: 445-456. Cherepkova MY et al (2016) Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death and Dis 7: e2050. Chesney J et al (2005) Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality, Biochem Biophys Res Commun 331: 139-146. Clem B et al (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110-120. Domenech E et al (2015) AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nat Cell Biol 17: 1304-1316. Griesel BA et al (2021) PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development. FASEB J 35: e21728. Hamanaka RB et al (2017) PFKFB3, a direct target of p63, is required for proliferation and inhibits differentiation in epidermal keratinocytes. J Invest Dermatol 137: 1267-1276. Hirai HJ et al (2011) Regulation of embry- onic stem cell self-renewal and pluripotency by leu- kaemia inhibitory factor. Biochem J 438: 11- 23. Hong Y et al (1996) Establishment and growth responses of early medakafish ( Oryzias latipes ) embryonic cells in feeder layer-free cultures. Mol Mar Biol Biotechnol 5: 93-104. Kim Y et al (2014) Role of the epithelial–mesenchymal transition and its effects on embryonic stem cells. Exp Mol Med 46: e108. Kurek D et al (2015) Endogenous WNT Signals Mediate BMP-Induced and Spontaneous Differentiation of Epiblast Stem Cells and Human Embryonic Stem Cells. Stem Cell Rep 4: 114-128. Lee YL et al (2012) Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse emb ryonic fibroblasts through the miR-34a and p53 pathways. PLoS One 7: e 45633. Livak KJ et al (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408. Mathieu J et al (2017) Metabolic remodeling during the loss and acquisition of pluripotency. Development 144: 541-551. Mu WL et al (2015) Sox2 deacetylation by sirt1 is involved in mouse somatic reprogramming, Stem Cells 33: 2135-2147. Niwa H et al (2009) A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460: 118-122. Novellasdemunt L et al (2013) PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3). Atlas Genet Cytogenet Oncol Haematol 2013-03-01. Pegoraro C et al (2013) Pfkfb (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) isoforms display a tissue-specific and dynamic expression during Xenopus laevis development. Gene Expr Patterns 13: 203-211. Pegoraro C et al (2015) PFKFB4 controls embryonic patterning via Akt signalling independently of glycolysis. Nat Commun 6: 5953. doi: 10.1038/ncomms6953. Peng F et al (2018) PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis. 52: 945-954. Piquet-Pellorce C et al (1994) Are LIF and related cytokines functionally equivalent? Exp Cell Res 213: 340-347. Raz R et al (1999) Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 96: 2846-2851. Schaftingen EV et al (1982) A kinetic study of pyrophosphate:fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem FEBS 129: 191e195. Si X et al (2013) Activation of GSK3beta by Sirt2 is required for early lineage commitment of mouse embryonic stem cel. PLoS One 8: e76699. Song L et al (2016) Dynamic Heterogeneity of Brachyury in Mouse Epiblast StemCells Mediates Distinct Response to Extrinsic BoneMorphogenetic Protein (BMP) Signaling. J Biol Chem 291: 15212-15225. Tesar PJ et al (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 48:196-199. Weinberger L et al (2016). Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol 17: 155-169. Yalcin A et al (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86: 174-179. Yalcin A et al (2014) 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis 5: e1337. Zhou W et al (2012) HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J 31: 2103-2116. Zhu J et al (2016) Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT. Proc Natl Acad Sci USA 113: 3820-3825. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Major revision 21 Oct, 2022 Reviews received at journal 11 Oct, 2022 Reviewers agreed at journal 02 Oct, 2022 Reviewers invited by journal 02 Oct, 2022 Editor assigned by journal 30 Sep, 2022 Submission checks completed at journal 17 Sep, 2022 First submitted to journal 15 Sep, 2022 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-2068671","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":137430152,"identity":"e0a7697a-58e2-45bf-a537-96264086f7f0","order_by":0,"name":"Saime Guzel","email":"","orcid":"","institution":"Bursa Uludag University","correspondingAuthor":false,"prefix":"","firstName":"Saime","middleName":"","lastName":"Guzel","suffix":""},{"id":137430153,"identity":"5b10dd25-e84a-405e-85e5-ea86ac2685ac","order_by":1,"name":"Yunus Gurpinar","email":"","orcid":"","institution":"Koc University","correspondingAuthor":false,"prefix":"","firstName":"Yunus","middleName":"","lastName":"Gurpinar","suffix":""},{"id":137430155,"identity":"5c834229-e5eb-41a0-a212-25103beb0126","order_by":2,"name":"Tugba Hazal Altunok","email":"","orcid":"","institution":"Bursa Uludag University","correspondingAuthor":false,"prefix":"","firstName":"Tugba","middleName":"Hazal","lastName":"Altunok","suffix":""},{"id":137430157,"identity":"f06c33bd-54a3-4028-92f0-18903bd9d13f","order_by":3,"name":"Abdullah Yalcin","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA7UlEQVRIiWNgGAWjYHACxgMMBgxyDOwMDBJg/gEi9IC0GDMwI7QwNhDWwsCQ2EC0Fv4ZyQ8O/Ci4k77hMI/hjR+/GOT4biSwP67Ao0XiRprBwR6DZ7lALcaWvX0MxpI3Ehgbz+Cz5kaCwWEGg8MgLWYSvD0MiRtAWvC5TP5G+geQlnQDoBbJvz0M9QS1GNzIAduSANIizfODIcGAkBbDM28KgH45bDjzMFuxtWyDhOHMMw8bZ+LTInc8feODH38Oy/Mdb954880fGyAj+cBHfFoYBBKQOIxtoKghFJP8B5B5f/ArHgWjYBSMgpEJAKgOWCkps9HIAAAAAElFTkSuQmCC","orcid":"","institution":"Bursa Uludag University","correspondingAuthor":true,"prefix":"","firstName":"Abdullah","middleName":"","lastName":"Yalcin","suffix":""}],"badges":[],"createdAt":"2022-09-15 11:44:26","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-2068671/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-2068671/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":26738891,"identity":"bfd24120-5d1b-4b8d-ae11-5a4d4a24158a","added_by":"auto","created_at":"2022-09-20 23:23:20","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":221618,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eLIF removal induces differentiation of R1 and J1 mESCs.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e(A)\u003c/strong\u003e Morphology of R1 and J1 mESCs grown in the presence (LIF+) and absence (LIF-) of LIF for 5 d. \u003cstrong\u003e(B)\u003c/strong\u003e mRNA expression levels of pluripotency genes Oct4, Klf4, Sox2 and Nanog in undifferentiated and LIF-depleted mESCs. \u003cstrong\u003e(C)\u003c/strong\u003e mRNA expression levels of the differentiation genes Brachyury and Nestin in mESCs grown in the presence (+) of and absence (-) of LIF for 5 d. Gapdh was used as internal control. Data are presented as mean±s.d. of an experiment that was conducted in triplicate (n=3). *p˂0.05, **p˂0.01 compared to LIF (+) control. \u003cstrong\u003e(D)\u003c/strong\u003e Western blot analysis of Nanog in R1 mESCs, and Stat3/p-Stat3 activity in R1 and J1 mESCs. Gapdh was used as loading control. \u003cstrong\u003e(E) \u003c/strong\u003eAlkaline phosphatase staining of R1 and J1 mESCs cultured on gelatin-coated plates with (+)/without (-) LIF.\u003c/p\u003e","description":"","filename":"1.png","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/4233b8d72a68c51eeb88510a.png"},{"id":26737941,"identity":"d7026b77-0ea1-4f78-81c3-225f65786de8","added_by":"auto","created_at":"2022-09-20 23:18:20","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":57524,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eDifferentiation of mESCs leads to an increase in Pfkfb3 expression.\u003c/strong\u003e \u003cstrong\u003e(A\u003c/strong\u003e) mRNA expression levels of Pfkfb isoenzymes in R1 and J1 mESCs grown with (+)/without (-) LIF for 5d. \u003cstrong\u003e(B)\u003c/strong\u003e Western blot analysis of the Pfkfb3 protein in R1 and J1 mESCs grown with/without for 3 d and 5 d. \u003cstrong\u003e(C)\u003c/strong\u003e F2,6BP levels of mESCs grown grown with/without LIF for 3 d and 5 d. \u003cstrong\u003e(D)\u003c/strong\u003e2DG uptake of mESCs grown grown with/without LIF for 5 d. \u003cem\u003e*p˂0.05, **p˂0.001 \u003c/em\u003ecompared to LIF (+) control.\u003c/p\u003e","description":"","filename":"2.png","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/353aa72b29b5ce9247b852d8.png"},{"id":26737942,"identity":"2f32fc0d-cec2-460d-8246-53019b0de138","added_by":"auto","created_at":"2022-09-20 23:18:21","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":21214,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003ePfkfb3 silencing induces differentiation marker Brachyury expression in R1and J1 mESCs.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eR1 and J1 cells grown in presence of LIF (+) were transfected with either non-targeting control (siNTC) or PFKFB3-specific siRNA (siPF3) molecules. The following day, the media was replaced new media with (+)/without (-) LIF. Forthy-eight hours later, Pfkfb3, Brachyury and nestin mRNA levels were analyzed by\u003cstrong\u003e \u003c/strong\u003eqPCR .\u003cem\u003e*p˂0.05.\u003c/em\u003e\u003c/p\u003e","description":"","filename":"3.png","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/f35436e7e39eb58ff360f9c1.png"},{"id":26737938,"identity":"a3b31856-d65c-451f-963e-b895125e3328","added_by":"auto","created_at":"2022-09-20 23:18:20","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":41172,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eIncrease in Pfkfb3 expression is required for proliferation of early differentiated mESCs.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e(A) \u003c/strong\u003eqPCR analyses of Pfkfb3 mRNA levels of R1 and J1 cells transfected either with non-targeting control (siNTC) or PFKFB3-specific siRNA (siPF3) molecules that were grown with (+)/without (-) LIF. \u003cstrong\u003e(B)\u003c/strong\u003e Cell counts of R1 and J1 cells transfected either with non-targeting control (siNTC) or PFKFB3-specific siRNA (siPF3) molecules that were grown with (+)/without (-) LIF. \u003cem\u003e*p˂0.05\u003c/em\u003e\u003cstrong\u003e.\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"4.png","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/182081f641c59f4bd950ea83.png"},{"id":26737939,"identity":"259e57f1-852c-48bf-a925-c29c806f36ed","added_by":"auto","created_at":"2022-09-20 23:18:20","extension":"png","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":41225,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eForced Pfkfb3 expression stimulates the proliferation of early differentiated mESCs.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e(A) \u003c/strong\u003eqPCR analyses of Pfkfb3 mRNA levels in R1 and J1 cells that were transfected with a plasmid encoding Pfkfb3 cDNA (PFKFB3-V), or an empty vector (Vector). \u003cstrong\u003e(B) \u003c/strong\u003eCell counts of the trasfected R1 and J1 cells that were grown with (+)/without (-) LIF. \u003cem\u003e*p˂0.05\u003c/em\u003e\u003c/p\u003e","description":"","filename":"5.png","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/5602823cec4154b88f09369a.png"},{"id":26738896,"identity":"c7454d5b-846b-4419-a450-d02e6d9e7d57","added_by":"auto","created_at":"2022-09-20 23:23:25","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":808345,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-2068671/v1/bc55e1c3-e86f-4ca9-a439-19af2c49f6d8.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for proliferation of mouse embryonic stem cells that are undergoing differentiation","fulltext":[{"header":"Introduction","content":"\u003cp\u003ePluripotent stem cells (PSCs) are characterized by their unlimited capacity for self-renewal and their potential to differentiate into all cell lineages of three primary germ layers. Different states of pluripotency exhibit slightly different features. The naive state represents the inner cell mass (ICM) of the early blastocyst while the primed state is representative of the early post-implantation epiblast cells. After implantation occurs, the epiblast cells progressively lose expression of pluripotency genes such as Oct4 and Nanog (Weinberger et al. \u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e2016\u003c/span\u003e; Mathieu et al. \u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). Embryonic stem cells (ESCs) are derived from the ICM of pre-implantation blastocyst stage of embryos. Mouse ESCs (mESCs) resemble naive state whereas post-implantation epiblast stem cells (mEpiSCs) and human ESCs (hESCs) are considered a primed PSC. While leukemia inhibitory factor (LIF) is a crucial factor for robust self-renewal of mESCs, mEpiSCs can be grown in vitro without LIF in the presence of activin A and fibroblast growth factor (FGF) (Brons et al. \u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2007\u003c/span\u003e; Tesar et al. \u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e2007\u003c/span\u003e). During culture, EpiSCs exhibit a high propensity for spontaneous differentiation (Kurek et al. \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e2015\u003c/span\u003e). The transition from the mESC to the mEpiSC state is the initial important step for ESCs to commit to differentiation. In vitro, first stages of spontaneous differentiation of mESCs can mimic this transition, but the mechanisms underlying this process are largely unknown.\u003c/p\u003e \u003cp\u003ePSCs exhibit a lower rate of Oxidative Phosphorylation (OXPHOS) than their differentiated counterparts; however, metabolism in naive and primed pluripotency occurs differently. Glycolysis is common to all stages of pluripotency; however, the relative contributions of glycolysis versus OXPHOS can differ in different stages of pluripotency. While mEpiSCs and hESCs are almost exclusively glycolytic, mESCs use both glycolysis and OXPHOS pathways (Lee et al. \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e2012\u003c/span\u003e; Zhou et al. \u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e2012\u003c/span\u003e; Si et al. \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e2013\u003c/span\u003e; Mu et al. \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e2015\u003c/span\u003e; Cha et al. \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e2017\u003c/span\u003e). Early embryonic development occurs in a hypoxic environment which occurs as a result of the high oxygen consumption and cellular proliferation of the rapidly growing embryo. In a hypoxic environment, the heterodimeric transcription factor hypoxia-inducible factor 1 (HIF1α), the main regulator of molecular response to hypoxia, plays a crucial role in tissue formation and stem cell homeostasis. HIF-1α upregulation stimulates the expression of glycolytic genes such as hexokinase (HK), lactate dehydrogenase (LDH), pyruvate dehydrogenase kinase (PDK1). Elucidation of the metabolic genes and pathways that are involved in pluripotency, differentiation, and proliferation of ESCs may help us better understand the molecular basis of early embryonic development as well as devise therapeutic strategies for various indications.\u003c/p\u003e \u003cp\u003eGlycolysis is indirectly regulated by the bifunctional 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatases isoenzymes (PFKFB1-4) which determine the intracellular concentration of fructose 2,6-bisphosphate (F2,6BP)-a shunt product of glycolysis and allosteric activator of one of the rate-limiting enzymes of glycolysis, 6-phosphofructo-1-kinase (PFK-1) (Yalcin et al. \u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e2009\u003c/span\u003e). PFKFB enzymes have been shown to be involved in cell proliferation (Yalcin et al. \u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e2014\u003c/span\u003e), cell survival (Domenech et al. \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e2015\u003c/span\u003e), cell differentiation (Hamanaka et al. \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e2017\u003c/span\u003e), and tumor growth (Clem et al. \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e2008\u003c/span\u003e). A recent study (Novellasdemunt et al. \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e2013\u003c/span\u003e) has revealed that the mouse Pfkfb3 mRNA becomes detectable during the blastocyst stage of embryogenesis. Chesney et al. (\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2005\u003c/span\u003e) demonstrated that the genomic deletion of Pfkfb3 results in embryonic lethality. Pegoraro et al. (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e2013\u003c/span\u003e) shows that tissue-specific, dynamic and complementary expression pattern of the PFKFB genes play an important role in the developmental stage of the Xenopus laevis (African clawed frog) embryos from blastula to tadpole stages. In another recent study by the same team (Pegoraro et al. \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e2015\u003c/span\u003e), Pfkfb4, by acting through Akt signaling pathway, has been shown to be essential in the development of frog embryos and differentiation of progenitor cells. However, studies on potential roles of Pfkfb isoenzymes in stem cell differentiation and metabolism are scarce.\u003c/p\u003e \u003cp\u003eIn the current study, we studied the expression of Pfkfb isoenzymes in mESCs that are self-renewing (in the presence of LIF) and that are induced to spontaneously differentiate (upon LIF removal). We show, for the first time, that the differentiation of mESCs for 5 day (d) upon LIF removal resulted in an increase in Pfkfb3 expression. In addition, we demonstrate that the Pfkfb3 silencing was associated with the increased expression of the differentiation marker Brachyury. We further demonstrate that increased expression of Pfkfb3 is required for the proliferation of early differentiated mESCs in vitro.\u003c/p\u003e"},{"header":"Materials And Methods","content":"\u003ch2\u003eCell culture and mESC differentiation\u003c/h2\u003e\n\u003cp\u003eMouse embryonic stem R1 (ATCC, SCRC1036) and J1 (ATCC, SCRC 1010) cell lines were grown in tissue culture dishes (Corning, Amsterdam, The Netherlands) coated with 0.1% gelatin (Sigma, Munchen, Germany) in a Dulbecco\u0026rsquo;s modified Eagle\u0026rsquo;s medium (DMEM) (Sigma, Munchen, Germany) supplemented with 15% ESC-qualified fetal bovine serum (Sigma, Munchen, Germ any), 0.1mM MEM non-essential amino acids (Sigma), 0.1 mM 2-mercaptoethanol (Sigma, Munchen, Germany), L glutamin (Sigma), 100 U/ml penicillin-100 ug/ml streptomisin mix and 1000 units/ml of recombinant mouse LIF. mESCs were cultured at 37\u0026deg;C in a humidified atmosphere with 5% CO2. Cells were passaged every 3 or 4 d using trypsin EDTA. Media were changed every 2 d. Spontaneous differentiation was induced with the removal of LIF from media.\u003c/p\u003e\n\u003ch2\u003eReal-time quantitative PCR (qPCR)\u003c/h2\u003e\n\u003cp\u003eTotal RNA was isolated using a commercial kit (Thermo Fisher Sci.) and reverse-transcribed using an mRNA to cDNA synthesis kit (Thermo Fisher Sci. Cat.#4387406) according to manufacturer\u0026rsquo;s directions. mRNA expressions of Pfkfb1, Pfkfb2, Pfkfb3, Pfkfb4, Brachyury (T2), Nestin (Nes), Oct4, Sox2, Nanog, Klf4 mRNA expressions, were determined by qPCR using StepOnePlus (Thermo Fisher Sci., NY, USA) with TaqMan probes (Thermo Fischer Sci., Cat.#s: Pfkfb1, Mm01256237_m1; Pfkfb2, Mm00435575_m1; Pfkfb3, Mm00504650_m1; Pfkfb4, Mm00557176_m1; T2, Mm00436877_m1; NES, Mm00450205_m1; Oct4, Mm03053917_g1; Sox2, Mm03053810_s1; Nanog, Mm02019550_s1; Klf4, Mm00516104_m1; Gapdh, Mm99999915_g1). Gapdh was used as housekeeping gene control for normalization of cDNA. Cycle threshold (CT) values were taken from qPCR reactions and up/down regulation of genes of interest was determined by the \u0026Delta;\u0026Delta;CT method using undifferentiated mESCs as a baseline (Livak et al. \u003cspan class=\"CitationRef\"\u003e2001\u003c/span\u003e).\u003c/p\u003e\n\u003ch2\u003eSDS-PAGE and Western blotting\u003c/h2\u003e\n\u003cp\u003eSDS-PAGE and Western blotting were performed following standard protocols. Primary antibodies specific to Pfkfb3 (Proteintech Cat.#13763-1-AP), P-Stat3 (Cell Signaling Cat.#9145), Stat3 (Cell Signaling Cat.#9139), Nanog (Cell Signaling Cat.#8822), and Gapdh (Cell Signaling Cat.#97166) proteins were used. Appropriate horseradish peroxidase-conjugated secondary antibodies (goat anti-rabbit, Cell Signaling Cat.#7074 or anti-mouse Cell Signaling Cat.#7076) were used. Signals were developed using Amersham ECL plus chemoluminescent reagent (GE Technologies). Bands on membranes were visualized with ChemiDoc MP (BioRad).\u003c/p\u003e\n\u003ch2\u003esiRNA and plasmid transfection\u003c/h2\u003e\n\u003cp\u003eTransfections of and Pfkfb3-specific (Thermo Fischer Sci. Cat.#100779) siRNA molecules into cells was performed in serum-free and antibiotic-free medium using Lipofectamine RNAiMAX (ThermoFisher Sci.) following the manufacturer\u0026rsquo;s recommendations when cells reached approximately 50% confluency at the time of transfection. As a negative control, cells were transfected with the universal siRNA molecule, which has no homology in the human genome (Thermo Fischer Sci. Cat.# 4390846). Cells were incubated in complete medium at 37\u0026deg;C for 48 hours before cell harvest or further experiments. The final concentrations of siRNA molecules were 10 nM.\u003c/p\u003e\n\u003cp\u003eFor ectopic expressions, pCMV6-A-BSD expression vector encoding Pfkfb3 cDNA (Origene Cat. #MG227622) was transfected into cells using Lipofectamine 3000 reagent (ThermoFisher Sci.) following the manufacturer\u0026rsquo;s instructions. Cells were 70\u0026ndash;80% confluent at the time of transfection.\u003c/p\u003e\n\u003ch2\u003eCell proliferation\u003c/h2\u003e\n\u003cp\u003ePluripotent and differentiated (for 5 d) mESCs were lifted with trypsin post-transfections and stained with trypan blue for 1 min. The numbers of viable cells were counted under an inverted microscope (Accu-Scope, China) using hemocytometer (Neubauer improved) as per standard protocol.\u003c/p\u003e\n\u003ch2\u003eFructose 2,6-bisphosphate assay\u003c/h2\u003e\n\u003cp\u003eIntracellular fructose 2,6-bisphosphate (F2,6BP) levels of differentiated (for 3 and 5 d) and undifferentiated mESCs were analyzed following a Kinetic spectrophotometric coupled enzyme method described by Van Schaftingen et al. (\u003cspan class=\"CitationRef\"\u003e1982\u003c/span\u003e). The protocol briefly as follows; mESCs were centrifuged at 270\u0026times;g and resuspended in 20 volumes of 0.05 N NaOH and then 1 volume of 0.1 N NaOH vortexed for 10 s, heatted at 80\u0026deg;C for 5 min, and cooled in an ice bath. PH of lysates adjusted to 7.2 with ice-cold 1M acetic acid in the presence of 1M Hepes. Next, samples were incubated at 25\u0026deg;C for 2 min in the assay mixture. The contents of the assay mixture were as follows: 50 mM Tris, 2 mM Mg\u003csup\u003e⁺2\u003c/sup\u003e, 1 mM Fru-6-P, 10 units/liter PPi-dependent PFK1, 0.15 mM NAD, 5 kilounit/liter triose-phosphate isomerase, 0.45 kilounit/liter aldolase, and 1.7 kilounit/liter glycerol-3-phoshate dehydrogenase (Sigma). Reaction was started adding 0.5 mM Pyrophosphate and the rate of changes in absorbance (OD 339 nm) per min was analyzed in 5 min. F2,6BP levels were calculated based on a calibration curve ranging from 0.1 to 1.0 pmol standart of Fru-2,6-BP (Sigma) and normalized to total cellular protein levels.\u003c/p\u003e\n\u003ch2\u003eGlucose uptake assay\u003c/h2\u003e\n\u003cp\u003eTo determine glucose uptake by pluripotent and differentiated (for 5 d) mESCs, a commercial glucose uptake kit (BioVision, Milpitas, CA, USA) was used in accordance with the manufacturer\u0026apos;s instructions. The principle of this assay is briefly as follows: 2-deoxyglucose (2-DG) is metabolized to 2-DG-6-phosphate (2-DG6P) which cannot be further metabolized, and thus accumulates in the cells. The accumulated 2-DG6P is directly proportional to 2-DG (or glucose) uptake by cells. 2-DG6P is oxidized to generate NADPH, which can be determined by an enzymatic recycling amplification reaction.\u003c/p\u003e\n\u003ch2\u003eALP staining\u003c/h2\u003e\n\u003cp\u003eAlkaline phosphatase (ALP) Live Stain kit (Thermo Fischer Sci. Cat.#A14353) was used to determine ALP activity in pluripotent and differentiated mESCS. Staining was performed for 20\u0026ndash;30 min according to manufacturer\u0026apos;s instructions. The protocol was briefly as follows; R1 and J1 mESCs were washed twice with sterile, fresh, pre-warmed basal DMEM/F-12 media. For differentiated and undifferentiated mESCs, 1X working solution which was prepared by diluting the 500X stock solution of the LIVE AP substrate in basal DMEM/F-12 media, was found to be optimal in providing a potent signal. The ALP live stain dye was immediately applied on to the adherent mESC culture. mESCs were incubated with the substrate for 20\u0026ndash;30 min and washed twice with the DMEM/F-12 basal media to remove excess substrate. After the final wash, fresh basal media was added and fluorescent-labeled colonies were imaged on EVOS Imaging System (ThermoFischer Sci.). The most robustly fluorescing colonies were selected for imaging within 30\u0026ndash;40 min of staining.\u003c/p\u003e\n\u003cdiv class=\"Section2\" id=\"Sec3\"\u003e\n \u003ch2\u003eStatistical analysis\u003c/h2\u003e\n \u003cp\u003eThe Statistical Package for the Social Sciences version 23.0 (SPSS, Chicago, IL, USA) was used for data analyses. Values were expressed as means\u0026thinsp;\u0026plusmn;\u0026thinsp;standard deviation. Statistical analysis was performed using Student\u0026rsquo;s t-test and results were considered to be significant when p value was \u0026lt;\u0026thinsp;0.05.\u003c/p\u003e\n\u003c/div\u003e"},{"header":"Results And Discussion","content":"\u003ch2\u003eLIF withdrawal induces differentiation of mESCs\u003c/h2\u003e\n\u003cp\u003eThe LIF/STAT3 pathway has a crucial role in maintaining the self renewal and pluripotency of the mESCs (Raz et al. \u003cspan class=\"CitationRef\"\u003e1999\u003c/span\u003e; Hirai et al. \u003cspan class=\"CitationRef\"\u003e2011\u003c/span\u003e). Upon the withdrawal of LIF, mESCs rapidly exit from the pluripotent state in vitro. A recent study in mESCs has shown that LIF remowal induces transition from the naive pluripotent state to the primed-like state with expression of early differentiation markers through activation of mTOR (Cherepkova et al. \u003cspan class=\"CitationRef\"\u003e2016\u003c/span\u003e). First, we evaluated the morphological features of R1 and J1 mESCs growing in the absence or presence of LIF. The morphology of the cells that are induced to differentiate for 5 d acquired some morphological characteristics compared to undifferentiated mESCs. While undifferentiated R1 and J1 mESCs grew as compact, dome-shaped colonies, the cells appeared more scattered, less compact and more flattened upon LIF removal (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eA).\u003c/p\u003e\n\u003cp\u003eqPCR analysis demonstrated that the LIF withdrawal from media in R1 and J1 mESCs for 5 d led to decreases in expression levels of pluripotency genes, including Oct4 (R1, p˂0.05; J1, p˂0.01), Klf4 (p˂0.01), Sox2 (p˂0.01) and Nanog (p˂0.05) (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eB). A recent study showed that the induction of early differentiation in LIF-depleted mESCs proceeds by KLF4-mediated regulation of pluripotency related pathways (Cherepkova et al. \u003cspan class=\"CitationRef\"\u003e2016\u003c/span\u003e). Western blot analysis was used to confirm the decrease in the Nanog protein in differentiated R1 mESCs (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eD). Consistent with downregulation of pluripotency gene marker expressions, mRNA levels of brachyrury (R1, p˂0.01; J1 p˂0.05), a widely used early marker of mesodermal differentiation and Nestin (R1 and J1, p˂0.01) (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eC), a neuroectodermal stem cell marker, were upregulated upon LIF removal. Among the intracellular signaling pathways that are regulated by LIF, Jak-Stat3 is known to be essential for the self-renewal and pluripotency of mESCs (Niwa et al. \u003cspan class=\"CitationRef\"\u003e2009\u003c/span\u003e). Upon LIF stimulation, Stat3 is phosphorylated and activated by Jaks, which subsequently stimulates the expressions of various pluripotency-associated genes (Hirai et al. \u003cspan class=\"CitationRef\"\u003e2011\u003c/span\u003e; Cherepkova et al. \u003cspan class=\"CitationRef\"\u003e2016\u003c/span\u003e). We checked the phosphorylation of the Stat3 protein in the presence or absence of LIF and found that LIF removal reduced Stat3 phosphorylation (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eD).\u003c/p\u003e\n\u003cp\u003eAlkaline phosphatase activity is another valuable marker for pluripotent mESCs. High ALP activity in pluripotent mESCs is reduced or lost upon differentiation (Piquet-Pellorce et al. \u003cspan class=\"CitationRef\"\u003e1994\u003c/span\u003e; Hong et al. \u003cspan class=\"CitationRef\"\u003e1996\u003c/span\u003e). We therefore went on to determine ALP activity in undifferentiated and differentiated mESCs. As expected, while the undifferentiated R1 and J1 mESCs displayed a robust ALP activity as asssessed by staining of the cells with a fluorescent ALP subsrate, the LIF-depleted cells displayed no activity (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003eE), suggesting that LIF removal induced the differentiation of mESCs.\u003c/p\u003e\n\u003ch2\u003eEarly differentiation of mESCs leads to an increase in Pfkfb3 expression\u003c/h2\u003e\n\u003cp\u003eAlthough the roles of Pfkfb isoenzymes in proliferation and survival of tumor cells are well-studied (Yalcin et al. \u003cspan class=\"CitationRef\"\u003e2014\u003c/span\u003e; Peng et al. \u003cspan class=\"CitationRef\"\u003e2018\u003c/span\u003e), potential roles of Pfkfb3 isoenzymes in proliferation and differentiation of mESCs are currently unknown. We first compared the expressions of Pfkfb isoenzymes in undifferentiated and early differentiated mESCs. J1 and R1 mESCs were cultured in the presence and absence of LIF for 5 d and mRNA levels of Pfkfb genes (Pfkfb1-4) were determined using qPCR. LIF withdrawal in both cell lines resulted in an increase in the expression of Pfkfb3 (p˂0.001) and Pfkfb4 (p˂0.05) isoenzymes, while no significant differences were determined in the expressions of Pfkfb1 and Pfkfb2 isoenzymes (Fig. \u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003eA). Because the most significant increase was observed with Pfkfb3 expression, we focused our attention on this isoform. Increased Pfkfb3 mRNA expressions in differentiated R1 and J1 mESCs coincided with increases in Pfkfb3 protein levels as assessed by Western blot analyses (Fig. \u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003eB). Consistent with the increases in mRNA and protein levels of Pfkfb3 isoenzyme, the intracellular F2,6BP level was significantly elevated in early differentiated mESCs (3 d and 5 d) relative to undifferentiated mESCs (p\u0026thinsp;\u0026lt;\u0026thinsp;0.001) (Fig. \u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003eC). LIF-depleted mouse ESCs have been shown to transit from the pluripotent state to the primed-like state, which exhibits a glycolytic phenotype (Zhou et al. \u003cspan class=\"CitationRef\"\u003e2012\u003c/span\u003e). Our findings show that a higher Pfkfb3 and F2,6BP levels upon LIF removal are consistent with the glycolytic phenotype reported by Zhou et al. (\u003cspan class=\"CitationRef\"\u003e2012\u003c/span\u003e). However, we found that LIF-depleted cells exhibited a diminished glucose uptake compared with undifferentiated R1 mESCs (p˂0.05) (Fig. \u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003eD). Although it is difficult to reconcile these seemingly contradictory findings, as increased Pfkfb3 and F2,6BP levels are known to be associated with increased glucose uptake and glycolytic activity, we speculate that, given the dymanic feature of differentiation, the reliance of mESCs undergoig differentiation on glycolysis vs. OXPHOS may markedly be divergent in various stages of differentiation. For example, the highly glycoltic mESCs during the early stages of differentiation (\u0026lt;\u0026thinsp;5 d of differentiation) may begin to rely on OXPHOS as the cells become more differentiated (\u0026gt;\u0026thinsp;5 d). Lending support to this hypothesis, the study by Ando et al. (\u003cspan class=\"CitationRef\"\u003e2010\u003c/span\u003e) that was published during the preparation of our manuscript that showed a diminished glucose uptake that coincided with a decreased Pfkfb3 level on day 6 compared with day 3 postdifferentiation in early differentiated adipocytes. However, we refrain from over-speculating regarding the data, as the setup and cell types were different in these studies. Another likely scenario is that given that the activation of the IL-6/STAT3 pathway in LIF-containing media induces glycolysis as shown by Ando et al. (\u003cspan class=\"CitationRef\"\u003e2010\u003c/span\u003e), and that removing LIF may have uncoupled glucose uptake and glycolysis from pluripotency signals such as STAT3. In this scenario, although glucose uptake was reduced with LIF removal, the induction of Pfkfb3 may be necessary to maintain the glucose uptake and glycolytic flux in early differentiation of mESCs. The observed upregulation of Pfkfb3 may reflect a compensatory feedback mechanism in LIF-depleted (day 5) mESCs and may diminish on further days of differentiation, which will require further investigations.\u003c/p\u003e\n\u003ch2\u003ePfkfb3 silencing induces Brachyury expression in mESCs.\u003c/h2\u003e\n\u003cp\u003eThe mouse Brachyury (T) is a key regulator of mesoderm formation during early embryonic development (Zhu et al. \u003cspan class=\"CitationRef\"\u003e2016\u003c/span\u003e) and essential for epithelial mesenchymal transition (EMT) which is important for embryonic development and EpiSCs differentiation (Kim et al. \u003cspan class=\"CitationRef\"\u003e2014\u003c/span\u003e; Song et al. \u003cspan class=\"CitationRef\"\u003e2016\u003c/span\u003e). Although there are studies suggesting the involvement of Pfkfb3 on differentiation of preadipocytes (Griesel et al. \u003cspan class=\"CitationRef\"\u003e2021\u003c/span\u003e) and epidermal keratinocytes (Hamanaka et al. \u003cspan class=\"CitationRef\"\u003e2017\u003c/span\u003e), the potential role of Pfkfb3 in early differentiation of mESCs is unknown. To investigate the requirement of Pfkfb3 for the early differentiation of mESCs, we analyzed gene expression levels of the differentiation markers brachyrury and nestin in control- or Pfkfb3-siRNA transfected ceIls, in the presence and absence of LIF. qPCR analyses demonstrated that the Pfkfb3 gene silencing led to an increase in the expression level of Brachyury gene in both of differentiated and undifferentiated mESC lines (p˂0.05), while there were no changes in the expressions of nestin gene (Fig. \u003cspan class=\"InternalRef\"\u003e3\u003c/span\u003e: average mRNA fold changes of siNTCs or siPF3s; \u003cstrong\u003eBrachyury\u003c/strong\u003e: \u003cem\u003eR1 cell line\u003c/em\u003e LIF+, siNTC\u0026thinsp;=\u0026thinsp;1\u0026thinsp;\u0026plusmn;\u0026thinsp;0.17 and siPF3\u0026thinsp;=\u0026thinsp;1.99\u0026thinsp;\u0026plusmn;\u0026thinsp;0.35; LIF-, siNTC\u0026thinsp;=\u0026thinsp;1,99\u0026thinsp;\u0026plusmn;\u0026thinsp;0.55 and siPF3\u0026thinsp;=\u0026thinsp;2.55\u0026thinsp;\u0026plusmn;\u0026thinsp;0.42; \u003cem\u003eJ1 cell line\u003c/em\u003e LIF+, siNTC\u0026thinsp;=\u0026thinsp;1\u0026thinsp;\u0026plusmn;\u0026thinsp;0.19 and siPF3\u0026thinsp;=\u0026thinsp;1.58\u0026thinsp;\u0026plusmn;\u0026thinsp;0.36; LIF-, siNTC\u0026thinsp;=\u0026thinsp;2,17\u0026thinsp;\u0026plusmn;\u0026thinsp;0.19 and siPF3\u0026thinsp;=\u0026thinsp;3.05\u0026thinsp;\u0026plusmn;\u0026thinsp;0.36; \u003cstrong\u003eNestin\u003c/strong\u003e: \u003cem\u003eR1 cell line\u003c/em\u003e LIF+, siNTC\u0026thinsp;=\u0026thinsp;1\u0026thinsp;\u0026plusmn;\u0026thinsp;0.048 and siPF3\u0026thinsp;=\u0026thinsp;0.91\u0026thinsp;\u0026plusmn;\u0026thinsp;0.02; LIF-, siNTC\u0026thinsp;=\u0026thinsp;2.52\u0026thinsp;\u0026plusmn;\u0026thinsp;0.40 and siPF3\u0026thinsp;=\u0026thinsp;2.29\u0026thinsp;\u0026plusmn;\u0026thinsp;0.02; J1 cell line LIF+, siNTC\u0026thinsp;=\u0026thinsp;1\u0026thinsp;\u0026plusmn;\u0026thinsp;0.03 and siPF3\u0026thinsp;=\u0026thinsp;0.98\u0026thinsp;\u0026plusmn;\u0026thinsp;0.04; LIF-, siNTC\u0026thinsp;=\u0026thinsp;5.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.15 and siPF3\u0026thinsp;=\u0026thinsp;5.80\u0026thinsp;\u0026plusmn;\u0026thinsp;0.18) and pluripotency gene markers, Sox2, Nanog, Oct4, Klf4 (\u003cem\u003edata not shown\u003c/em\u003e). These data suggest that Pfkb3 may have a role in the regulation of barchyury-mediated mesodermal differentiation of mESCs in the early embryonic period, which is consistent with a recent study demonstrating that Pfkfb3 knockdown promoted the differentiation of epidermal keratinocytes (Hamanaka et al. \u003cspan class=\"CitationRef\"\u003e2017\u003c/span\u003e).\u003c/p\u003e\n\u003ch2\u003eIncrease in Pfkfb3 expression is required for proliferation of early differentiated mESCs\u003c/h2\u003e\n\u003cp\u003eGiven the known role of Pfkfb3 in cell proliferation (Yalcin et al. \u003cspan class=\"CitationRef\"\u003e2009\u003c/span\u003e, \u003cspan class=\"CitationRef\"\u003e2014\u003c/span\u003e), we then evaluated cell counts in the presence and absence of LIF after Pfkfb3 siRNA transfection and overexpression. We first confirmed the effiency of Pfkfb3 mRNA targeting by the siRNA approach using qPCR (Fig. \u003cspan class=\"InternalRef\"\u003e4\u003c/span\u003eA). We found that while Pfkfb3 depletion led to a decreased cell counts upon LIF withdrawal, it increased cell counts in the presence of LIF (p˂0.05) (Fig. \u003cspan class=\"InternalRef\"\u003e4\u003c/span\u003eB). We then ectopically transfected R1 and J1 mESCs in the presence and absence of LIF with expression vector carrying Pfkfb3 (Pfkfb3-V) and empty plasmid for control. Ectopic transfections led to marked increases in Pfkfb3 mRNA levels (Fig. \u003cspan class=\"InternalRef\"\u003e5\u003c/span\u003eA). In contrast to the Pfkfb3 silencing, ectopic Pfkfb3 expression reduced the proliferation of mEScs growing in the presence of LIF but stimulated the growth of mESCs that are induced to spontaneously differentiate with LIF removal (Fig. \u003cspan class=\"InternalRef\"\u003e5\u003c/span\u003eB). Consistent with a decrease in glucose uptake upon LIF removal, cell proliferation was diminished in LIF-depleted cells. Our observation that Pfkfb3 depletion further reduces the proliferation of early differentiated mESCs suggests that mESCs that are undergoing spontaneous differentiation may rely on increased Pfkfb3 levels to maintain glycolytic phenotype that is associated with proliferation.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eIn summary, the present study demonstrates that LIF-depletion induces Pfkfb3 expression and that Pfkfb3 may be required for differentiation and proliferation of mESCs. Mechanistic studies will be needed to fully delineate the requirement of PFKFB isoenzymes for differentiation of stem cells into specialized cells. Better understanding of specific molecular mechanisms or pathways of stem cell differentiation may provide us with valuable tools that can be exploited in various disciplines of medicine.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003ePFKFB, 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase; mESCs, mouse embryonic stem cells; LIF, leukemia inhibitory factor.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis work was supported by the Scientific Research Fund of Bursa Uludag University [grant number# OUAP(V)-2013/27] and Scientific and Technological Research Council of Turkey [grant number#116Z570).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eFunding\u0026nbsp;\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis work was supported by the Scientific Research Fund of Bursa Uludag University [grant number# OUAP(V)-2013/27] and Scientific and Technological Research Council of Turkey [grant number#116Z570).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eAuthor Information\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors and Affiliations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDepartment of Biochemistry, School of Veterinary Medicine, Bursa Uludag University, Bursa, Turkey\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSaime Guzel, Tugba H Altunok, Abdullah Yalcin\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Center for Translational Medicine, Koc University, Istanbul 34010, Turkey\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eYunus Gurpinar\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eContributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eConceptualization: SG \u0026amp; AY; Acquisition and Analysis: SG, THA \u0026amp; YG; Funding Acquisition: SG; Writing: SG; Review and Editing: AY\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCorresponding Author\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCorrespondence to Abdullah Yalcin or Saime Guzel\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eEthics Declarations\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflict of interest\u0026nbsp;\u003c/strong\u003eThe authors declare that they have no conflicts of interests.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics Approval\u003c/strong\u003e Not applicable\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to participate\u003c/strong\u003e Not applicable\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData Availability\u0026nbsp;\u003c/strong\u003eThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eAndo M et al (2010) Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. J Nippon Med Sch 77: 97-105.\u003c/li\u003e\n\u003cli\u003eBrons I et al (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195.\u003c/li\u003e\n\u003cli\u003eCha Y et al (2017) Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c\u0026ndash;SIRT2 axis. Nat Cell Biol 19: 445-456. \u003c/li\u003e\n\u003cli\u003eCherepkova MY et al (2016) Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death and Dis 7: e2050.\u003c/li\u003e\n\u003cli\u003eChesney J et al (2005) Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality, Biochem Biophys Res Commun 331: 139-146.\u003c/li\u003e\n\u003cli\u003eClem B et al (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110-120.\u003c/li\u003e\n\u003cli\u003eDomenech E et al (2015) AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nat Cell Biol 17: 1304-1316.\u003c/li\u003e\n\u003cli\u003eGriesel BA et al (2021) PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development. FASEB J 35: e21728.\u003c/li\u003e\n\u003cli\u003eHamanaka RB et al (2017) PFKFB3, a direct target of p63, is required for proliferation and inhibits differentiation in epidermal keratinocytes. J Invest Dermatol 137: 1267-1276.\u003c/li\u003e\n\u003cli\u003eHirai HJ et al (2011) Regulation of embry- onic stem cell self-renewal and pluripotency by leu- kaemia inhibitory factor. Biochem J 438: 11- 23.\u003c/li\u003e\n\u003cli\u003eHong Y et al (1996) Establishment and growth responses of early medakafish (\u003cem\u003eOryzias latipes\u003c/em\u003e) embryonic cells in feeder layer-free cultures. Mol Mar Biol Biotechnol 5: 93-104.\u003c/li\u003e\n\u003cli\u003eKim Y et al (2014) Role of the epithelial\u0026ndash;mesenchymal transition and its effects on embryonic stem cells. Exp Mol Med 46: e108.\u003c/li\u003e\n\u003cli\u003eKurek D et al (2015) Endogenous WNT Signals Mediate BMP-Induced and Spontaneous Differentiation of Epiblast Stem Cells and Human Embryonic Stem Cells. Stem Cell Rep 4: 114-128.\u003c/li\u003e\n\u003cli\u003eLee YL et al (2012) Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse emb ryonic fibroblasts through the miR-34a and p53 pathways. PLoS One 7: e 45633. \u003c/li\u003e\n\u003cli\u003eLivak KJ et al (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408.\u003c/li\u003e\n\u003cli\u003eMathieu J et al (2017) Metabolic remodeling during the loss and acquisition of pluripotency. Development 144: 541-551.\u003c/li\u003e\n\u003cli\u003eMu WL et al (2015) Sox2 deacetylation by sirt1 is involved in mouse somatic reprogramming, Stem Cells 33: 2135-2147.\u003c/li\u003e\n\u003cli\u003eNiwa H et al (2009) A parallel circuit of LIF signalling pathways \u2028maintains pluripotency of mouse ES cells. Nature 460: 118-122.\u003c/li\u003e\n\u003cli\u003eNovellasdemunt L et al (2013) PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3). Atlas Genet Cytogenet Oncol Haematol 2013-03-01.\u003c/li\u003e\n\u003cli\u003ePegoraro C et al (2013) Pfkfb (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) isoforms display a tissue-specific and dynamic expression during Xenopus laevis development. Gene Expr Patterns 13: 203-211. \u003c/li\u003e\n\u003cli\u003ePegoraro C et al (2015) PFKFB4 controls embryonic patterning via Akt signalling independently of glycolysis. Nat Commun 6: 5953. doi: 10.1038/ncomms6953.\u003c/li\u003e\n\u003cli\u003ePeng F et al (2018) PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis. 52: 945-954.\u003c/li\u003e\n\u003cli\u003ePiquet-Pellorce C et al (1994) Are LIF and related cytokines functionally equivalent? Exp Cell Res 213: 340-347.\u003c/li\u003e\n\u003cli\u003eRaz R et al (1999) Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 96: 2846-2851.\u003c/li\u003e\n\u003cli\u003eSchaftingen EV et al (1982) A kinetic study of pyrophosphate:fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem FEBS 129: 191e195.\u003c/li\u003e\n\u003cli\u003eSi X et al (2013) Activation of GSK3beta by Sirt2 is required for early lineage commitment of mouse embryonic stem cel. PLoS One 8: e76699. \u003c/li\u003e\n\u003cli\u003eSong L et al (2016) Dynamic Heterogeneity of Brachyury in Mouse Epiblast StemCells Mediates Distinct Response to Extrinsic BoneMorphogenetic Protein (BMP) Signaling. J Biol Chem 291: 15212-15225.\u003c/li\u003e\n\u003cli\u003eTesar PJ et al (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 48:196-199.\u003c/li\u003e\n\u003cli\u003eWeinberger L et al (2016). Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol 17: 155-169.\u003c/li\u003e\n\u003cli\u003eYalcin A et al (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86: 174-179.\u003c/li\u003e\n\u003cli\u003eYalcin A et al (2014) 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis 5: e1337.\u003c/li\u003e\n\u003cli\u003eZhou W et al (2012) HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J\u003cem\u003e \u003c/em\u003e31: 2103-2116. \u003c/li\u003e\n\u003cli\u003eZhu J et al (2016) Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT. Proc Natl Acad Sci USA 113: 3820-3825.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"cytotechnology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"cyto","sideBox":"Learn more about [Cytotechnology](http://link.springer.com/journal/10616)","snPcode":"10616","submissionUrl":"https://submission.nature.com/new-submission/10616/3","title":"Cytotechnology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Mouse embryonic stem cells, 6-Phosphofructo-2-kinase/Fructose 2,6-bisphosphatase-3, Brachyury, Leukemia inhibitory factor","lastPublishedDoi":"10.21203/rs.3.rs-2068671/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-2068671/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eThe unlimited proliferation capacity of embryonic stem cells (ESCs) coupled with their capability to differentiate into several cell types makes them an attractive candidate for studying the molecular mechanisms regulating self renewal and transition from pluripotent state. Although the roles of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase family (PFKFB1-4) in cell survival, proliferation, and differentiation in tumor cells have been studied, their role in mESCs biology is currently unkown. In the current study, Pfkfb isozyme expressions were analyzed in undifferentiated R1 and J1 mouse embryonic stem cells (mESCs) that were cultured in the presence and absence of leukemia inhibitory factor (LIF). We report that expression of the Pfkfb3 isoenzyme was markedly increased when mESCs were promoted to differentiate with LIF removal. We then demonstrated that Pfkfb3 silencing induced the differentiation marker Brachyury suggesting that Pfkfb3 may be required for the regulation of mesodermal differentiation of mESCs. Furthermore, we show that the increase in Pfkfb3 expression is required for the proliferation of early differentiated mESCs. Although these results provide important insights into the early differentiation of mESCs with regard to Pfkfb expressions, further mechanistic studies will be needed for understanding the pathways and mechanisms involved in regulation of proliferation and early differentiation of mESCs through Pfkfb3.\u003c/p\u003e","manuscriptTitle":"Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for proliferation of mouse embryonic stem cells that are undergoing differentiation","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2022-09-20 23:18:18","doi":"10.21203/rs.3.rs-2068671/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Major revision","date":"2022-10-22T03:46:41+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2022-10-11T20:58:27+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"a5fcc282-36f0-4689-9526-7521d9fe6dae","date":"2022-10-02T17:47:44+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2022-10-02T06:44:30+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2022-09-30T15:48:09+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2022-09-17T11:43:30+00:00","index":"","fulltext":""},{"type":"submitted","content":"Cytotechnology","date":"2022-09-15T11:36:53+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"cytotechnology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"cyto","sideBox":"Learn more about [Cytotechnology](http://link.springer.com/journal/10616)","snPcode":"10616","submissionUrl":"https://submission.nature.com/new-submission/10616/3","title":"Cytotechnology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"9fed80c7-ec68-48ab-94a3-b0e74ec4d233","owner":[],"postedDate":"September 20th, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2022-11-01T02:44:22+00:00","versionOfRecord":[],"versionCreatedAt":"2022-09-20 23:18:18","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-2068671","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-2068671","identity":"rs-2068671","version":["v1"]},"buildId":"_2-kVJe1T_tPrBINL-cwx","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-29T02:00:03.542394+00:00
License: CC-BY-4.0